Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

NCT03564938 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Regorafenib (Stivarga, BAY73-4506)

Sponsor

Bayer